Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ONC | BEONE MEDICINES LTD | $320.30 | $19.23 | 1,565.58% | 6,406.00x | 96.01x | 7.10x | 8.59x | 6.19x | $529.27M | 1.50% | $4.13B | 37.48 | $33.35B | 104.86 | ||
| NVO | NOVO NORDISK A S | $55.11 | $148.58 | -62.91% | 15.33x | 2.39x | 5.04x | 9.35x | 0.16x | $9.34B | 3.81% | $26.18B | 5.89 | $255.53B | 10.30 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $397.83 | $36.70 | 984.14% | 1,283.32x | 57.17x | 16.29x | 224.71x | 4.17x | $221.36M | 0.42% | $233.89M | 1.78 | $54.28B | 357.29 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $41.06 | $17.31 | 137.18% | 83.80x | 23.86x | 5.13x | 5.81x | 1.04x | $101.73M | 3.32% | $535.38M | 7.17 | $2.95B | 55.01 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $8.34 | $16.40 | -49.15% | 17.38x | 14.67x | 5.53x | 3.53x | 0.22x | -$23.64M | -5.07% | $133.17M | 2.38 | $477.80M | 7.11 | ||
| CORT | CORCEPT THERAPEUTICS INC | $34.95 | $43.04 | -18.80% | 34.95x | 31.80x | 4.88x | 5.82x | 0.34x | $162.57M | 4.49% | $631.90M | 6.10 | $3.56B | 53.92 | ||
| VCEL | VERICEL CORP | $37.08 | $9.53 | 289.22% | 142.62x | 63.78x | 7.24x | 5.83x | 1.69x | $20.38M | 1.09% | $321.86M | 6.38 | $1.87B | 63.90 | ||
| ARGX | ARGENX SE | $800.88 | $361.56 | 121.51% | 32.00x | 27.13x | 25,834.84x | 6.82x | 1.34x | $467.72M | 0.96% | $7.17B | 117.50 | $46.48B | 57.29 | ||
| KRYS | KRYSTAL BIOTECH INC | $244.71 | $115.60 | 111.69% | 35.47x | 30.50x | 18.99x | 6.24x | 1.18x | $166.02M | 2.34% | $1.14B | 39.30 | $6.71B | 34.73 | ||
| TECH | BIO-TECHNE CORP | $63.03 | $16.26 | 287.57% | 126.06x | 31.17x | 8.05x | 5.00x | 1.72x | $224.06M | 2.29% | $1.97B | 12.65 | $10.07B | 45.59 | ||
| GMAB | GENMAB A | $31.80 | $127.88 | -75.13% | 13.57x | 1.82x | 5.73x | 3.55x | 0.10x | $1.19B | 5.85% | $5.75B | 8.96 | $18.80B | 9.40 | ||
| ABEO | ABEONA THERAPEUTICS INC | $5.22 | $19.08 | -72.64% | 3.28x | -96.85x | 745.71x | 1.65x | 0.19x | -$82.36M | -29.08% | $171.23M | 3.16 | $223.76M | 2.49 | ||
| ADMA | ADMA BIOLOGICS INC | $18.03 | $12.71 | 41.88% | 20.49x | 20.09x | 8.80x | 9.95x | 0.86x | $40.73M | 0.95% | $431.19M | 1.81 | $4.30B | 25.00 | ||
| XOMA | XOMA ROYALTY CORP | $26.62 | $15.82 | 68.26% | 32.86x | 84.67x | 6.86x | 3.75x | 0.87x | -$12.41M | -3.84% | $87.94M | 7.25 | $371.07M | 13.87 | ||
| AUPH | AURINIA PHARMACEUTICALS INC | $15.30 | $9.83 | 55.63% | 26.38x | 16.04x | 7.59x | 5.51x | 0.86x | $119.87M | 5.94% | $365.77M | 2.78 | $2.02B | 19.53 | ||
| VCYT | VERACYTE INC | $43.63 | $12.31 | 254.39% | 111.87x | 41.47x | 6.94x | 2.74x | 1.59x | $98.21M | 2.86% | $1.26B | 15.98 | $3.17B | 55.66 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $192.03 | $72.23 | 165.87% | 83.13x | 22.82x | 14.96x | 3.98x | 1.19x | $30.76M | 0.82% | $950.17M | 48.53 | $4.09B | 39.71 | ||
| CRMD | CORMEDIX INC | $12.19 | $17.80 | -31.53% | 5.37x | 4.84x | 4.32x | 2.57x | 0.93x | $74.42M | 8.04% | $374.13M | 4.93 | $1.06B | 9.45 | ||
| MNKD | MANNKIND CORP | $5.62 | $2.78 | 102.41% | 56.20x | 51.23x | 5.49x | -38.74x | 0.93x | $43.39M | 2.51% | -$44.55M | -0.15 | $1.96B | 26.76 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $6.45 | $4.32 | 49.44% | 23.89x | 21.44x | 4.13x | 7.28x | 0.85x | $21.15M | 4.11% | $70.68M | 0.89 | $453.51M | 19.99 | ||
| RPRX | ROYALTY PHARMA PLC | $39.65 | $47.16 | -15.93% | 22.53x | 7.66x | 7.29x | 2.38x | 0.39x | $2.11B | 12.33% | $9.62B | 22.28 | $30.89B | 29.59 | ||
| EXEL | EXELIXIS INC | $42.40 | $36.52 | 16.09% | 17.24x | 13.42x | 4.97x | 5.26x | 0.69x | $779.77M | 6.85% | $2.16B | 8.05 | $11.17B | 12.04 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $448.80 | $190.20 | 135.97% | 31.36x | 21.95x | 9.79x | 6.57x | 1.52x | $3.34B | 2.91% | $17.32B | 67.76 | $110.76B | 23.76 | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $1.79 | $3.57 | -49.83% | 25.57x | 10.12x | 2.29x | 2.72x | 0.21x | -$11.69M | -8.21% | $52.91M | 0.67 | $138.48M | 15.61 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $58.87 | $51.34 | 14.66% | 21.64x | 13.06x | 3.65x | 1.87x | 0.60x | $832.13M | 7.36% | $6.06B | 31.54 | $10.66B | 13.79 | ||
| APLS | APELLIS PHARMACEUTICALS INC | $24.87 | $6.67 | 272.92% | 71.06x | -22.39x | 3.09x | 7.84x | 1.95x | $78.64M | 2.50% | $401.17M | 3.17 | $3.14B | 33.64 | ||
| HALO | HALOZYME THERAPEUTICS INC | $71.20 | $80.68 | -11.75% | 14.56x | 8.59x | 6.72x | 16.62x | 0.50x | $602.40M | 7.22% | $503.92M | 4.30 | $9.46B | 11.19 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $36.75 | $61.16 | -39.91% | 11.38x | 8.70x | 2.56x | 2.53x | 0.32x | $296.89M | 14.04% | $835.12M | 14.51 | $1.64B | 6.08 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $22.80 | $22.61 | 0.83% | 12.74x | 11.69x | 4.83x | 3.05x | 0.68x | $234.54M | 8.39% | $920.25M | 7.51 | $2.11B | 6.53 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $763.23 | $412.12 | 85.20% | 17.57x | 16.57x | 5.55x | 2.59x | 1.72x | $4.22B | 5.34% | $30.96B | 298.82 | $80.41B | 14.08 | ||
| MDXG | MIMEDX GROUP INC | $6.33 | $5.05 | 25.27% | 22.61x | 25.33x | 2.38x | 3.92x | 0.67x | $66.82M | 7.12% | $238.95M | 1.61 | $813.62M | 11.76 | ||
| INVA | INNOVIVA INC | $20.03 | $19.37 | 3.43% | 10.60x | 9.17x | 3.56x | 1.48x | 0.86x | $196.54M | 14.21% | $1.01B | 14.63 | $1.28B | 5.95 | ||
| UTHR | UNITED THERAPEUTICS CORP | $489.69 | $251.10 | 95.02% | 17.19x | 16.46x | 6.86x | 3.20x | 2.04x | $1.12B | 5.23% | $6.59B | 150.46 | $19.74B | 11.13 | ||
| ACAD | ACADIA PHARMACEUTICALS INC | $26.15 | $12.34 | 111.86% | 16.66x | 32.48x | 4.22x | 4.82x | 2.87x | $197.81M | 4.48% | $917.27M | 5.43 | $4.20B | 14.60 | ||
| INCY | INCYTE CORP | $101.79 | $77.27 | 31.74% | 16.85x | 12.65x | 4.14x | 4.30x | 0.87x | $1.20B | 6.01% | $4.65B | 23.77 | $17.56B | 10.44 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.